Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7507 USD | +9.90% | +3.83% | -46.76% |
03-27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
03-26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.76% | 32.96M | |
+72.92% | 12.38B | |
-19.68% | 7.92B | |
+16.20% | 7.2B | |
+6.78% | 5.84B | |
+7.49% | 5.07B | |
+23.97% | 4.53B | |
-21.67% | 3.88B | |
-41.54% | 2.23B | |
+1.24% | 2.02B |
- Stock Market
- Equities
- LUCD Stock
- News Lucid Diagnostics Inc.
- Cantor Fitzgerald Starts Lucid Diagnostics at Overweight With $21 Price Target